Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
60
+11 vs. Q2 2022
Portfolio value
$2.02B
+$577.8M (+39.9%) vs. Q2 2022
Filed
Nov 14, 2022
SEC
Holdings of Deep Track Capital, LP in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
ISEEIVERIC bio, Inc.COM7,000,000$125.6M6.2%+2,500,000+55.6%AddedHistory
JAZZJazz Pharmaceuticals plcSHS USD861,000$114.8M5.7%+361,000+72.2%AddedHistory
TVTXTravere Therapeutics, Inc.COM4,000,000$98.6M4.9%+419,300+11.7%AddedHistory
NVCRNovoCure LtdORD SHS1,293,761$98.3M4.9%−47,539−3.5%ReducedHistory
HZNPHorizon Therapeutics Public Ltd CoSHS1,462,800$90.5M4.5%+1,462,800NewHistory
ASNDAscendis Pharma A/SSPONSORED ADR800,000$82.6M4.1%+800,000NewHistory
SWTXSpringWorks Therapeutics, Inc.COM2,369,210$67.6M3.3%+2,369,210NewHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS2,900,000$67.5M3.3%00.0%UnchangedHistory
BMRNBiomarin Pharmaceutical IncCOM738,863$62.6M3.1%+84,498+12.9%AddedHistory
KDNYChinook Therapeutics, Inc.COM3,000,000$59.0M2.9%−430,110−12.5%ReducedHistory
IMVTImmunovant, Inc.COM9,860,246$55.0M2.7%+405,246+4.3%AddedHistory
AGENAgenus IncCOM NEW26,325,000$54.0M2.7%+4,083,583+18.4%AddedHistory
BEAMBeam Therapeutics Inc.COM1,000,000$47.6M2.4%−250,000−20.0%ReducedHistory
KURAKura Oncology, Inc.COM3,186,083$43.5M2.2%−511,886−13.8%ReducedHistory
AUPHAurinia Pharmaceuticals Inc.COM5,677,372$42.7M2.1%+5,677,372NewHistory
DYNDyne Therapeutics, Inc.COM3,184,200$40.4M2.0%−315,800−9.0%ReducedHistory
VRDNViridian Therapeutics, Inc.COM1,970,290$40.4M2.0%+800,000+68.4%AddedHistory
RPTXRepare Therapeutics Inc.COM3,127,667$37.9M1.9%+420,005+15.5%AddedHistory
ABOSAcumen Pharmaceuticals, Inc.COM3,778,818$37.9M1.9%+678,818+21.9%AddedHistory
ESPREsperion Therapeutics, Inc.COM5,636,587$37.8M1.9%−363,413−6.1%ReducedHistory
NKTXNkarta, Inc.COM2,814,844$37.0M1.8%00.0%UnchangedHistory
HRTXHeron Therapeutics, Inc.COM8,548,387$36.1M1.8%+8,548,387NewHistory
EWTXEdgewise Therapeutics, Inc.COM3,374,394$33.2M1.6%+3,374,394NewHistory
FATEFate Therapeutics IncCOM1,311,113$29.4M1.5%−706,892−35.0%ReducedHistory
PLRXPliant Therapeutics, Inc.COM1,399,744$29.2M1.4%+1,399,744NewHistory
VRNAVerona Pharma plcSPONSORED ADS2,829,094$28.9M1.4%+2,829,094NewHistory
ALLKAllakos Inc.COM4,518,575$27.7M1.4%+4,518,575NewHistory
AKROAkero Therapeutics, Inc.COM790,926$26.9M1.3%+790,926NewHistory
NRIXNurix Therapeutics, Inc.COM2,053,621$26.8M1.3%−382,543−15.7%ReducedHistory
VERVVerve Therapeutics, Inc.COM775,000$26.6M1.3%+775,000NewHistory
KALVKalVista Pharmaceuticals, Inc.COM1,824,000$26.5M1.3%00.0%UnchangedHistory
FDMT4D Molecular Therapeutics, Inc.COM3,196,642$25.7M1.3%+56,642+1.8%AddedHistory
THRDThird Harmonic Bio, Inc.COM1,268,220$24.1M1.2%+1,268,220NewHistory
GBTGlobal Blood Therapeutics, Inc.COM326,600$22.2M1.1%−3,320,090−91.0%ReducedHistory
VIGLVigil Neuroscience, Inc.COM2,363,188$21.5M1.1%+2,054,795+666.3%AddedHistory
ALBOAlbireo Pharma, Inc.COM1,110,624$21.5M1.1%+1,110,624NewHistory
NUVBNuvation Bio Inc.COM CL A9,325,540$20.9M1.0%−2,145,741−18.7%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,053,000$20.7M1.0%00.0%UnchangedHistory
DICEDICE Therapeutics, Inc.COM1,000,000$20.3M1.0%−42,900−4.1%ReducedHistory
SLNSilence Therapeutics plcADS1,951,580$19.6M1.0%+1,000,000+105.1%AddedHistory
FMTXForma Therapeutics Holdings, Inc.SHS966,573$19.3M1.0%−3,083,427−76.1%ReducedHistory
ARDXArdelyx, Inc.COM14,858,000$17.7M0.9%+14,858,000NewHistory
RLMDRelmada Therapeutics, Inc.COM460,861$17.1M0.8%−39,139−7.8%ReducedHistory
NTLAIntellia Therapeutics, Inc.COM300,000$16.8M0.8%+300,000NewHistory
ETNB89bio, Inc.COM2,636,000$15.3M0.8%+2,636,000NewHistory
TCDATricida, Inc.COM1,177,680$12.3M0.6%−1,554,437−56.9%ReducedHistory
ACETAdicet Bio, Inc.COM825,508$11.7M0.6%−66,520−7.5%ReducedHistory
JNCEJounce Therapeutics, Inc.COM4,259,653$9.97M0.5%00.0%UnchangedHistory
KROSKeros Therapeutics, Inc.COM248,500$9.35M0.5%−491,028−66.4%ReducedHistory
ANABAnaptysbio, IncCOM360,000$9.18M0.5%−312,569−46.5%ReducedHistory
IPSCCentury Therapeutics, Inc.COM924,641$9.14M0.5%00.0%UnchangedHistory
INZYInozyme Pharma, Inc.COM3,250,000$8.71M0.4%00.0%UnchangedHistory
DNTHDianthus Therapeutics, Inc.COM5,359,000$7.56M0.4%00.0%UnchangedHistory
FULCFulcrum Therapeutics, Inc.COM900,711$7.29M0.4%−99,289−9.9%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM5,035,998$6.75M0.3%00.0%UnchangedHistory
GHRSGH Research PLCORDINARY SHARES499,400$5.80M0.3%00.0%UnchangedHistory
ASMBAssembly Biosciences, Inc.COM3,000,000$4.92M0.2%00.0%UnchangedHistory
SDGRSchrodinger, Inc.COM170,000$4.25M0.2%−392,000−69.8%ReducedHistory
PASGPassage BIO, Inc.COM1,439,062$1.80M0.1%−880,938−38.0%ReducedHistory
GRTSGritstone bio, Inc.COM45,500$117.0K<0.1%−1,674,500−97.4%ReducedHistory

Options (5)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q3 2022
SecurityClassPutsCalls
ASNDAscendis Pharma A/SSPONSORED ADR–$103.3M
ISEEIVERIC bio, Inc.COM–$35.9M
TCDATricida, Inc.COM–$8.10M
RETAReata Pharmaceuticals IncCL A$7.96M–
RLMDRelmada Therapeutics, Inc.COM–$4.34M

Sold out since Q2 2022 (5)

Positions held at the end of Q2 2022 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q2 2022
SecurityClassShares in Q2 2022Value in Q2 2022% of portfolio in Q2 2022History
MDGLMadrigal Pharmaceuticals, Inc.COM905,000$64.8M4.5%History
ACADAcadia Pharmaceuticals IncCOM1,733,130$24.4M1.7%History
SAGESage Therapeutics, Inc.COM171,800$5.55M0.4%History
TNYATenaya Therapeutics, Inc.COM483,836$2.72M0.2%History
ATYRaTYR PHARMA INCCOM NEW290,844$823.0K0.1%History